Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting3
Unknown1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07596576Not ApplicableRecruiting

Sheba Healthspan Research Population (SHARP) Trial - Sheba Longevity Center Diagnostic and Intervention Protocol to Lower Biological Age in Older Adults

NCT06984510Recruiting

Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population

NCT06791486RecruitingPrimary

AI-Driven Prediction of Biological Age With EHR

NCT05588921Unknown

LensAge to Reveal Biological Age

Showing all 4 trials

Research Network

Activity Timeline